GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (SZSE:300347) » Definitions » Shiller PE Ratio

Hangzhou Tigermed Consulting Co (SZSE:300347) Shiller PE Ratio : 43.06 (As of Apr. 27, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Shiller PE Ratio?

As of today (2024-04-27), Hangzhou Tigermed Consulting Co's current share price is ¥57.70. Hangzhou Tigermed Consulting Co's E10 for the quarter that ended in Dec. 2023 was ¥1.34. Hangzhou Tigermed Consulting Co's Shiller PE Ratio for today is 43.06.

The historical rank and industry rank for Hangzhou Tigermed Consulting Co's Shiller PE Ratio or its related term are showing as below:

SZSE:300347' s Shiller PE Ratio Range Over the Past 10 Years
Min: 28.75   Med: 101.2   Max: 333.96
Current: 42.75

During the past years, Hangzhou Tigermed Consulting Co's highest Shiller PE Ratio was 333.96. The lowest was 28.75. And the median was 101.20.

SZSE:300347's Shiller PE Ratio is ranked worse than
70.51% of 78 companies
in the Medical Diagnostics & Research industry
Industry Median: 26.33 vs SZSE:300347: 42.75

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hangzhou Tigermed Consulting Co's adjusted earnings per share data for the three months ended in Dec. 2023 was ¥0.170. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥1.34 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hangzhou Tigermed Consulting Co Shiller PE Ratio Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Shiller PE Ratio Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 283.12 142.75 92.88 41.02

Hangzhou Tigermed Consulting Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 92.88 80.41 50.62 49.86 41.02

Competitive Comparison of Hangzhou Tigermed Consulting Co's Shiller PE Ratio

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Tigermed Consulting Co's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's Shiller PE Ratio falls into.



Hangzhou Tigermed Consulting Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hangzhou Tigermed Consulting Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=57.70/1.34
=43.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Tigermed Consulting Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Hangzhou Tigermed Consulting Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.17/114.6694*114.6694
=0.170

Current CPI (Dec. 2023) = 114.6694.

Hangzhou Tigermed Consulting Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.043 98.600 0.050
201406 0.041 98.200 0.048
201409 0.048 98.900 0.056
201412 0.061 99.000 0.071
201503 0.060 99.900 0.069
201506 0.060 99.500 0.069
201509 0.053 100.500 0.060
201512 0.069 100.600 0.079
201603 0.060 102.200 0.067
201606 0.051 101.400 0.058
201609 0.030 102.400 0.034
201612 0.059 102.600 0.066
201703 0.060 103.200 0.067
201706 0.099 103.100 0.110
201709 0.108 104.100 0.119
201712 0.141 104.500 0.155
201803 0.128 105.300 0.139
201806 0.164 104.900 0.179
201809 0.199 106.600 0.214
201812 0.206 106.500 0.222
201903 0.194 107.700 0.207
201906 0.276 107.700 0.294
201909 0.236 109.800 0.246
201912 0.417 111.200 0.430
202003 0.340 112.300 0.347
202006 0.990 110.400 1.028
202009 0.387 111.700 0.397
202012 0.490 111.500 0.504
202103 0.520 112.662 0.529
202106 0.920 111.769 0.944
202109 0.600 112.215 0.613
202112 1.260 113.108 1.277
202203 0.600 114.335 0.602
202206 0.780 114.558 0.781
202209 0.480 115.339 0.477
202212 0.460 115.116 0.458
202303 0.660 115.116 0.657
202306 0.950 114.558 0.951
202309 0.560 115.339 0.557
202312 0.170 114.669 0.170

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hangzhou Tigermed Consulting Co  (SZSE:300347) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Hangzhou Tigermed Consulting Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Tigermed Consulting Co (SZSE:300347) Business Description

Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Hangzhou Tigermed Consulting Co (SZSE:300347) Headlines

No Headlines